Literature DB >> 11595517

A discrepancy resolved: human satellite cells are not preprogrammed to fast and slow lineages.

S Bonavaud1, O Agbulut, R Nizard, G D'honneur, V Mouly, G Butler-Browne.   

Abstract

Satellite cells from chicken and mouse muscle when differentiated in vitro have been shown to display a myosin heavy chain phenotype that corresponds to the fibre from which they originated. Indirect evidence has suggested that this might not be the case for human satellite cells. In the present study we have compared the myosin heavy chain (MHC) profile expressed by differentiated cultures of satellite cells isolated from single fast or slow muscle fibres. The MHC composition of the isolated fibres was determined by sodium dodecyl sulfate glycerol gel electrophoresis and Western blotting. The MHC profile expressed by the differentiated myotubes was identified by immunostaining using specific antibodies. Our results show that all human satellite cells isolated from either fast or slow fibres form myotubes in vitro which co-express both fast and slow MHCs independently of the fibre type from which they originated. These results confirm that human satellite cells, in contrast to those of birds and rodents, are not confined to distinct fast and slow lineages.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11595517     DOI: 10.1016/s0960-8966(01)00222-x

Source DB:  PubMed          Journal:  Neuromuscul Disord        ISSN: 0960-8966            Impact factor:   4.296


  10 in total

Review 1.  Excitation-transcription coupling in skeletal muscle: the molecular pathways of exercise.

Authors:  Kristian Gundersen
Journal:  Biol Rev Camb Philos Soc       Date:  2010-10-06

2.  Cell Density and Joint microRNA-133a and microRNA-696 Inhibition Enhance Differentiation and Contractile Function of Engineered Human Skeletal Muscle Tissues.

Authors:  Cindy S Cheng; Lydia Ran; Nenad Bursac; William E Kraus; George A Truskey
Journal:  Tissue Eng Part A       Date:  2016-04       Impact factor: 3.845

Review 3.  Heterogeneity in the muscle satellite cell population.

Authors:  Stefano Biressi; Thomas A Rando
Journal:  Semin Cell Dev Biol       Date:  2010-09-19       Impact factor: 7.727

4.  Changes in myotonic dystrophy protein kinase levels and muscle development in congenital myotonic dystrophy.

Authors:  Denis Furling; Le Thanh Lam; Onnik Agbulut; Gillian S Butler-Browne; Glenn E Morris
Journal:  Am J Pathol       Date:  2003-03       Impact factor: 4.307

Review 5.  Skeletal Muscle Metabolic Alternation Develops Sarcopenia.

Authors:  Qiumei Yang; Piu Chan
Journal:  Aging Dis       Date:  2022-06-01       Impact factor: 9.968

6.  Comparative gene expression profiling between human cultured myotubes and skeletal muscle tissue.

Authors:  Frederic Raymond; Sylviane Métairon; Martin Kussmann; Jaume Colomer; Andres Nascimento; Emma Mormeneo; Cèlia García-Martínez; Anna M Gómez-Foix
Journal:  BMC Genomics       Date:  2010-02-22       Impact factor: 3.969

7.  Elevated SOCS3 and altered IL-6 signaling is associated with age-related human muscle stem cell dysfunction.

Authors:  Bryon R McKay; Daniel I Ogborn; Jeff M Baker; Kyle G Toth; Mark A Tarnopolsky; Gianni Parise
Journal:  Am J Physiol Cell Physiol       Date:  2013-02-07       Impact factor: 4.249

Review 8.  Skeletal myocyte plasticity: basis for improved therapeutic potential?

Authors:  Karlheinz Hilber
Journal:  Curr Opin Pharmacol       Date:  2008-03-07       Impact factor: 5.547

9.  Activation of Pax7-positive cells in a non-contractile tissue contributes to regeneration of myogenic tissues in the electric fish S. macrurus.

Authors:  Christopher M Weber; Mark Q Martindale; Stephen J Tapscott; Graciela A Unguez
Journal:  PLoS One       Date:  2012-05-31       Impact factor: 3.240

10.  Skeletal muscle myotubes in severe obesity exhibit altered ubiquitin-proteasome and autophagic/lysosomal proteolytic flux.

Authors:  Lance M Bollinger; Jonathan J S Powell; Joseph A Houmard; Carol A Witczak; Jeffrey J Brault
Journal:  Obesity (Silver Spring)       Date:  2015-06       Impact factor: 5.002

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.